ClinicalTrials.gg
CompletedNCT07529119Updated Sep 14, 2026

Effect of Consuming a Mango and Chia-based Beverage on Modulating the Intestinal Microbiota in Obese Children

An interventional study of Mango juice and Mango and chia juice in Microbiota, sponsored by Universidad Nacional de Caaguazu. Completed at 1 site in Paraguay. Open to participants aged 8 Years to 16 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-09-14.

Sponsored by Universidad Nacional de Caaguazu · Not applicable, Interventional, and Supportive care

Phase
Not applicable
Study type
Interventional
Enrollment
100
Allocation
Randomized
Ages
8 Years to 16 Years
Sex
All
01

Study summary

This randomized clinical trial evaluates the effect of a mango and chia-based beverage on gut microbiota modulation in 100 Paraguayan children aged 8-16 years with obesity. Participants will consume the intervention beverage for 4 weeks. Fecal samples will be collected before and after each intervention to analyze microbiota composition using 16S rRNA sequencing. This study aims to characterize the gut microbiota of Paraguayan children for the first time and assess whether this functional beverage can positively modulate intestinal bacteria as a potential strategy to address childhood obesity, which affects 1 in 3 school-age children in Paraguay.

02

Conditions studied

  • Microbiota
03

In context

Lead sponsor

Universidad Nacional de Caaguazu is the lead sponsor of 5 studies on the registry; 2 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
8 Years to 16 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

100 children aged 8-16 years from Paraguay, stratified by (with/without excess weight).

Exclusion criteria

Exclusion Criteria:

Allergyc to mango or chia

Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Investigator, Outcomes assessor)
Enrollment
100 participants (actual)

Study arms

  • Experimental
    Mango berverage

    Other: Mango juice

  • Active comparator
    Mango and chia berverage

    Other: Mango and chia juice

Interventions

  • OtherMango juice

    Mango juice drink for 4 weeks 200 ml daily, 5 days a week

  • OtherMango and chia juice

    Mango and chia juice drink for 4 weeks, 200 ml daily 5 days a week

06

What researchers measure

Primary outcomes

  1. Microbiota

    Gut microbiota composition analysis (16S rRNA sequencing)

    Time frame: Baseline and after 4 weeks

Secondary outcomes

  1. Anthropometric measurements

    Measure of weight

    Time frame: Baseline and after 4 weeks

07

Study locations

1 site
  • UNCA
    Coronel Oviedo, Paraguay
08

References and documents

Individual participant data

Plan to share: Yes — anonimyzed

Supporting information: Study protocol, Statistical analysis plan, Informed consent form, Clinical study report

Time frame: When the study end

Access criteria: Researchers

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from Feb 2026 to primary completion in May 2026, 2 months.

How these figures are worked out, and which studies are left out of them.

Registered
Feb 10, 2026
First posted
Apr 14, 2026
StartActual
Feb 9, 2026
Primary completionActual
May 2, 2026
CompletionActual
Jun 6, 2026
Last update
Sep 14, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Sep 14, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07529119
Lead sponsor
Universidad Nacional de Caaguazu
Responsible party
Sponsor
First posted
Apr 14, 2026
Start date
Feb 9, 2026
Primary completion
May 2, 2026
Completion
Jun 6, 2026
Last update
Sep 14, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Sep 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion